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Abstract
Background: Natural killer (NK) cells contribute to the defense against infected and transformed cells through the
engagement of multiple germline-encoded activation receptors. Stimulation of the Fc receptor CD16 alone is sufficient for
NK cell activation, whereas other receptors, such as 2B4 (CD244) and DNAM-1 (CD226), act synergistically. After receptor
engagement, protein kinases play a major role in signaling networks controlling NK cell effector functions. However, it has
not been characterized systematically which of all kinases encoded by the human genome (kinome) are involved in NK cell
activation.
Results: A kinase-selective phosphoproteome approach enabled the determination of 188 kinases expressed in human NK
cells. Crosslinking of CD16 as well as 2B4 and DNAM-1 revealed a total of 313 distinct kinase phosphorylation sites on 109
different kinases. Phosphorylation sites on 21 kinases were similarly regulated after engagement of either CD16 or co-
engagement of 2B4 and DNAM-1. Among those, increased phosphorylation of FYN, KCC2G (CAMK2), FES, and AAK1, as well
as the reduced phosphorylation of MARK2, were reproducibly observed both after engagement of CD16 and co-
engagement of 2B4 and DNAM-1. Notably, only one phosphorylation on PAK4 was differentally regulated.
Conclusions: The present study has identified a significant portion of the NK cell kinome and defined novel phosphorylation
sites in primary lymphocytes. Regulated phosphorylations observed in the early phase of NK cell activation imply these
kinases are involved in NK cell signaling. Taken together, this study suggests a largely shared signaling pathway
downstream of distinct activation receptors and constitutes a valuable resource for further elucidating the regulation of NK
cell effector responses.
Citation: Ko ¨nig S, Nimtz M, Scheiter M, Ljunggren H-G, Bryceson YT, et al. (2012) Kinome Analysis of Receptor-Induced Phosphorylation in Human Natural Killer
Cells. PLoS ONE 7(1): e29672. doi:10.1371/journal.pone.0029672
Editor: Jo ¨rg D. Hoheisel, Deutsches Krebsforschungszentrum, Germany
Received July 11, 2011; Accepted December 1, 2011; Published January 4, 2012
Copyright:  2012 Ko ¨nig et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the International Research Training Group 1273 funded by the German Research Foundation (Dr. Ko ¨nig, Dr. Scheiter, Dr.
Ja ¨nsch), the Histocytosis Association of America (Dr. Bryceson), Mary Beve’s Foundation (Dr. Bryceson), Clas Groschinsky’s Memorial Fund (Dr. Bryceson), Shizu
Matsumaras Donation (Dr. Bryceson), the Karolinska Institute Research Foundation (Dr. Bryceson and Dr. Ljunggren), the Swedish Research Council (Dr. Bryceson
and Dr. Ljunggren), and the Swedish Cancer Society (Dr. Ljunggren). The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors Dr. Ko ¨nig, Dr. Nimtz, Dr. Scheiter and Dr. Ja ¨nsch declare their affiliation to Helmholtz-Zentrum fuer Infektionsforschung
GmbH. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials.
* E-mail: lothar.jaensch@helmholtz-hzi.de
Introduction
Natural killer (NK) cells are lymphocytes belonging to the innate
immune system. They can eliminate infected or transformed cells
through direct killing of target cells [1]. Moreover, NK cells also
influence cells of the adaptive immune system through release of
chemokines and cytokines, as well as by contact-dependent killing
of activated immune cells [2,3]. The activation and effector
functions of NK cells are controlled by signals from a multiplicity
of germline-encoded activating and inhibitory receptors [4,5].
Downstream of receptor engagement, the underlying signaling
networks in NK cells are controlled by protein kinases [6,7,8],
which constitute the largest family of enzymes in the human
genome [9]. More than 500 different protein kinases coordinate
steps in virtually all intra-cellular signaling pathways. Generally,
protein kinases are expressed at relatively low levels and require
targeted approaches for their direct characterization [10].
Dynamic post-translational modifications, including phosphoryla-
tions, regulate the enzymatic activity, localization, and substrate
binding competence of kinases.
In terms of signaling by NK cell receptors, structurally distinct
inhibitory receptors all contain immunoreceptor tyrosine-based
inhibition motifs (ITIMs). The signaling by such motifs has been
extensively studied and is mediated by activation of tyrosine
phosphatases as well as the tyrosine kinase c-Abl [11,12]. In
contrast, activating NK cells receptors have highly divergent
cytoplasmic signaling domains, and signaling pathways orches-
trated by many activating NK cell receptors are not well defined.
The low affinity Fc receptor CD16 (FccRIIIA) is the prototypical
NK cell activating receptor. Engagement of CD16 induces SRC
tyrosine kinase-dependent phosphorylation of immunoreceptor
tyrosine-based activation motifs (ITAM) on the adaptor chains
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ZAP-70 tyrosine kinases for downstream signaling [13]. Engage-
ment of CD16 on NK cells is sufficient to induce NK cell
degranulation for antibody-dependent cellular cytotoxicity
(ADCC) [14]. Since several features of proximal CD16 signaling
are shared with that of the T cell receptor (TCR), downstream
events are thought to resemble those characterized in T cells.
However, signaling induced by different ITAM-coupled receptors
has not been rigorously compared. For natural cytotoxicity,
engagement of individual receptors normally does not suffice,
whereas co-engagement of specific pairwise combinations of
receptors can induce synergistic intracellular Ca
2+ mobilization
as well as degranulation and cytokine production [15,16]. Thus,
receptors such as 2B4 (CD244) and DNAM-1 (CD226) have been
termed ‘‘co-activating receptors’’ [15]. 2B4 binds CD48 [17], a
ligand ubiquitously expressed on hematopoeitic cells. 2B4 contains
cytoplasmic immunoreceptor tyrosine-based switch motifs
(ITSMs). These motifs are phosphorylated and can recruit either
phosphatases for negative regulation of NK cell functions, or, via
the adaptor SAP, the SRC kinase FYN for the activation of NK
cells [18,19,20]. In human NK cells, 2B4 is activating unless cells
are deficient in SAP, which is the case in the primary
immunodeficiency X-linked lymphoproliferative type 1 caused
by mutations in SH2D1A whereupon engagement of 2B4 results in
inhibitory signals [18,21]. DNAM-1 binds the widely expressed
nectins CD112 and CD155 [22]. The cytoplasmic domain of
DNAM-1 is phosphorylated by protein kinase C (PKC) [23].
Further downstream, signaling by DNAM-1 in NK cells is not well
understood but involves also serine and threonine phosphoryla-
tions rarely characterized in NK biology [24,25]. In terms of co-
activating receptor synergy, a recent report suggests that, rather
than complementary signaling between different receptors, the
basis for co-activation is dependent on a summation of signals
from each receptor for VAV1 activation to overcome an inhibitory
threshold set by c-Cbl [26].
In conclusion, further studies focusing at signaling downstream
of co-activating receptors and the prototypical NK cell activation
receptor CD16 are needed to identify common nodes as well as
pathway specificities of receptors with distinct cytoplasmic
domains, helping to define the core-signal network regulating
NK cell activation.
Mass spectrometry (MS) can provide insights into protein
phosphorylation events that coordinate signaling networks. In
particular, Fourier transform mass spectrometry (FTMS) routinely
achieves a very high data accuracy, facilitating unambiguous
protein sequencing and identification of amino acid site-specific
post-translational modifications [27]. Phosphoproteome studies
have already been performed on T cell lines, shedding light on
TCR signaling networks [28,29,30]. However, due to the
requirement for large cell amounts, only a few MS-based studies
have used primary lymphocytes [31]. Gaining access to signaling
components, such as protein kinases, is more methodologically
demanding and requires, in addition to significant amounts of
starting cell material, efficient pre-enrichment of target proteins.
Here, we use a kinase-selective phosphoproteome strategy to
probe receptor-induced kinase phosphorylation in primary human
NK cells. The results characterize the NK cell kinome including
the first unbiased knowledge about its phosphorylation. Quanti-
tative MS data reveal novel kinase phosphorylation sites that are
modulated following CD16 activation or co-engagement of 2B4
and DNAM-1. Notably, the regulatory patterns were remarkably
similar following activation through such distinct receptors,
suggesting a largely shared signal network. To our knowledge,
this study is the first proteome approach that specifically
determines receptor-dependent kinase phosphorylation in primary
lymphocytes.
Results
Expansion and characterization of primary NK cells
To obtain sufficient material for quantitative proteome studies,
NK cells were isolated from the peripheral blood of healthy
human donors and polyclonally expanded with irradiated,
allogeneic feeder cells and recombinant IL-2 (Figure S1). To
ensure that no gross perturbations in NK cell function occurred
upon NK cell expansion, the readouts of early signaling events in
IL-2–cultured NK cells were compared to those of freshly isolated
NK cells (Figure 1). Initially, NK cells were labeled with Ca
2+-
sensitive fluorescent dyes and incubated either with IgG isotype
control, anti-CD56 (both served as negative controls), anti-CD16,
anti-2B4, or anti-DNAM-1, as well as co-incubated with anti-2B4
and anti-DNAM-1 monoclonal antibodies (mAbs) on ice.
Thereafter, cells were pre-warmed for 5 minutes at 37uC and
analyzed on a flow cytometer. The strength and dynamics of
intracellular Ca
2+-mobilization were assessed in NK cells following
crosslinking with a secondary goat anti-mouse Fc antibody
(Figure 1A). Whereas isotype control mAbs or crosslinking of
CD56 did not elicit any Ca
2+-mobilization in IL-2–cultured NK
cells, crosslinking of CD16 induced a robust mobilization of
intracellular Ca
2+ similar, albeit diminished in magnitude, to that
observed in freshly isolated NK cells [15]. Crosslinking of either
2B4 or DNAM-1 did not induce Ca
2+-mobilization in IL-2–
cultured NK cells, as previously observed for freshly isolated NK
cells [15]. However, co-crosslinking of 2B4 and DNAM-1
synergized to produce intracellular Ca
2+-mobilization in IL-2–
cultured NK cells, again as previously described in freshly isolated
NK cells [15]. Next, we compared receptor-induced degranulation
in IL-2–cultured and freshly isolated NK cells (Figure 1B). NK
cell-susceptible human K562 cells and murine P815 cells (Fc
receptor-positive for redirected ADCC) were used as target cells.
NK cells were incubated with target cells and mAbs, as indicated,
for one hour followed by staining and analysis by flow cytometry.
Degranulation was quantified in terms of induced CD107a surface
expression. IL-2–cultured or freshly isolated NK cells did not
degranulate in response to P815 cells or P815 cells co-incubated
with isotype control or anti-CD56 mAb. However, engagement of
CD16 induced degranulation of both IL-2–cultured and freshly
isolated NK cells. Of note, degranulation was somewhat stronger
in freshly isolated NK cells, consistent with stronger Ca
2+-
mobilization in freshly isolated NK cells. Co-engagement of 2B4
and DNAM-1 resulted in synergistic degranulation by both IL-2–
cultured and freshly isolated NK cells, and degranulation induced
by incubation with K562 cells was also similar between IL-2–
cultured and freshly isolated NK cells. Moreover, comparison of
receptor expression by IL-2–cultured and freshly isolated NK cells
have previously revealed similar expression levels [15]. Taken
together, the IL-2–cultured NK cells retained sufficient functional
and phenotypic attributes of freshly isolated NK cells and were
thus well suited for studies of signal transduction events by
quantitative proteomics.
Kinase-selective phosphoproteome analyses of activated
NK cells
Kinase phosphorylation in receptor-activated and IgG isotype
control-treated NK cells were comparatively analyzed by the
quantitative proteome workflow depicted in Figure 2. In total,
three independent phosphokinome analyses were performed (two
included CD16 engagement, all three included 2B4 and DNAM-1
The Human NK Cell Kinome
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with IgG isotype control or indicated receptor-specific mAbs on
ice, pre-warmed to 37uC and crosslinked for 2 minutes (Figure 2A).
Notably, at this time-point the strength of intracellular Ca
2+-
mobilization induced by engagement of CD16 or co-engagement
of 2B4 and DNAM-1 was similar in magnitude (Figure 1A). After
stimulation, cell lysates were generated and protein kinases were
enriched as described in the following.
Sample complexity and high abundant proteins usually hamper
the systematic characterization of protein kinases by MS. Thus,
pre-enrichment of protein kinases from total cell lysates is
required. Immobilized ATP-competitive small kinase inhibitors
with a broad inhibitory spectrum can facilitate this step prior to
proteomic characterization [10,32,33,34]. Here, we used a serial
combination of the kinase inhibitors VI16743 and Purvalanol-B
that target a significant portion of the human kinome
[10,32,35,36]. Lysates generated from IL-2–cultured NK cells
stimulated by indicated receptors were subjected to small molecule
affinity chromatography (SMAC) for enrichment of protein
kinases (Figure 2B). Proteome analyses of the SMAC eluate
fractions revealed that approximately 30% of all identified proteins
could be classified as kinases according to the Swiss-Prot protein
knowledgebase (Figure S2A). Thus, kinases were the most
abundant proteins in the eluted fractions and were generally
Figure 1. Functional characterization of IL-2–cultured primary NK cells. (A) Intracellular Ca
2+-mobilization induced by activating NK cell
receptors. The following monoclonal antibodies (mAbs) were used for NK cell stimulation: negative controls, IgG isotype (cIgG, red) and anti-CD56
(dark blue); receptor stimulation, anti-2B4 (orange), anti-DNAM-1 (light blue), anti-CD16 (green) and anti-2B4 and anti-DNAM-1 (purple). Polyclonal IL-
2–cultured NK cells were pre-incubated with the indicated mAbs on ice and loaded with Fluo-4 and Fura Red dyes. Ca
2+-mobilization was assessed by
flow cytometry. After 30 sec, secondary F(ab9)2 goat anti-mouse IgG crosslinking antibody was added (black arrow). FL-1/FL-3 ratios are plotted as a
function of time. (B) Comparison of degranulation by freshly isolated (open bars) and IL-2–cultured (black bars) NK cells. NK cells were incubated with
the following target cells: murine P815 cells (negative control), P815 cells coated with mAbs to the indicated receptors (Fc receptor-positive for
redirected ADCC; IgG isotype and anti-CD56 mAb coated P815 cells were used as negative controls) or with NK cell-susceptible human K562 cells
(positive control). Subsequently, NK cells were stained with fluorochrome-conjugated anti-CD56 and anti-CD107a mAbs and analyzed by flow
cytometry. The percentage of CD107a-positive NK cells is shown as mean 6 standard deviation (SD) of at least eight independent experiments.
Differences between two groups were examined using the Student’s t-test (***, p,0.001). Correlation between degranulation by freshly isolated
(open bars) and IL-2–cultured (black bars) NK cells were determined according to Pearson (r=0.95).
doi:10.1371/journal.pone.0029672.g001
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corresponding peptide sequences than non-kinases (Figure S2B).
These results underline the efficient enrichment of protein kinases
from total cell lysates using immobilized kinase inhibitors VI16743
and Purvalanol-B. In total, the expression of 175 protein kinases
and 13 non-protein kinases (NPKs, kinases that have low
molecular weight phosphate acceptors as substrates) was unam-
biguously determined in human NK cells (Table S2). According to
a large-scale analysis of the human transcriptome suggesting the
expression of around 300 distinct kinases in human cells [37], this
chemical proteome approach characterized approximately 60% of
the kinases expressed in human NK cells. Moreover, an alignment
with the human kinome dendrogram [9] showed that kinases from
almost all branches of the human kinome were detected in IL-2–
cultured NK cells (Figure 3).
Next, all proteins of kinase-enriched SMAC-fractions were
digested into peptides and differentially labeled with isobaric
iTRAQ reagents (Figure 2C, D) required for peptide quantifica-
tion by MS (for details, see Materials and methods). Differentially
iTRAQ-labeled samples obtained from the respective stimula-
tions were combined and phosphopeptides were purified from
kinome-derived peptide mixtures by immobilized metal affinity
chromatography (IMAC) to ascertain their optimal characteriza-
tion by MS (Figure 2E). Phosphopeptide-depleted fractions
comprising IMAC flow-through and wash fractions were further
sub-fractionated by strong cation exchange (SCX) chromatogra-
phy (Figure 2F) to reduce ion suppression effects in MS and to
improve kinase sequence coverage. LC-MS/MS analyses
(Figure 2G) were performed with all fractions and provided
fragmentation data on both non-modified peptide sequences as
well as those carrying phosphorylations on serine, threonine, or
tyrosine residues (see Table S1 – Performed phosphokinome
experiments). Since iTRAQ reporter ions are cleaved from each
peptide under the condition of peptide sequencing simultaneous-
ly, each individual tandem MS fragment ion spectrum also
provides quantitative information (Figure 2H, I). Figure 4 shows a
representative MS/MS fragmentation spectra that depicts the
phosphorylation of KCC2G on S381 induced by engagement of
CD16 or co-engagement of 2B4 and DNAM-1: The detected
molecular masses of b- (red) and y- (blue) fragment ions identify
the phosphopeptide GS,TESCNTTTEDEDLK, which can be
exclusively assigned to the kinase KCC2G (Figure 4A). iTRAQ-
reporter ions appeared in the low molecular mass region of this
MS/MS spectrum indicating the relative abundance of this
phosphorylated peptide following the activation of NK cells by
engagement of CD16 (iTRAQ reporter 116) or co-engagement of
2B4 and DNAM-1 (iTRAQ reporter 115) in comparison to the
isotype control stimulation (iTRAQ reporter 114). The intensities
of the iTRAQ reporter masses 115 and 116 Dalton (Da)
confirmed that phosphorylation on S381 was induced by CD16
Figure 2. Proteome workflow for the detection of receptor-
induced kinase phosphorylation in NK cells. (A)H u m a n ,
polyclonal, IL-2–cultured NK cells were stimulated each with the
indicated receptor-specific monoclonal antibodies (mAbs) for 2 minutes
(right side) and in all cases were comparatively analyzed with non-
stimulated cells treated with control IgG isotype mAbs (cIgG) (left side).
(B) Protein kinases were purified from total lysates using VI16743/
Purvalanol-B-based small molecule affinity chromatography (SMAC). (C)
Kinase elution and digestion into tryptic peptides comprising all non-
modified and phosphorylated peptides. (D) Differential peptide labeling
with iTRAQ reagents for MS-based quantification of phosphorylation
site regulation and combination of samples. (E)E n r i c h m e n to f
phosphorylated peptides (phosphopeptides) by immobilized metal
affinity chromatography (IMAC). (F) Further fractionation of non-
phosphorylated peptide samples by strong cation exchange chroma-
tography (SCX). (G) Peptide sequence analysis (LC-MS/MS) of all peptide
fractions. (H) Peptide, kinase and phosphorylation site identification by
Mascot database search and manual MS data inspection. (I) Statistical
evaluation of significantly regulated phosphorylation sites on protein
kinases by the MS-specific noise model iTRAQassist [38].
doi:10.1371/journal.pone.0029672.g002
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PLoS ONE | www.plosone.org 4 January 2012 | Volume 7 | Issue 1 | e29672Figure 3. Protein kinases (kinome) expressed in human NK cells. The figure shows the human kinome dendrogram [9]. Kinase-selective
proteomics revealed the expression of 170 protein kinases (black and red circles), 5 atypical kinases (not depicted) and 13 non-protein kinases (NPKs,
not depicted). Phosphorylation site-specific information was obtained for 95 kinases (red circles), whereas no such information was obtained for the
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example of the statistical evaluation of receptor-induced kinase
phosphorylations by the MS-specific noise model iTRAQassist
[38] is shown for CD16-induced phosphorylation of KCC2G
(Figure 4B). Curves indicating most and less likely regulations,
which must be considered based on the experimental results.
Distinct and non-overlapping curves basically indicated signifi-
cant regulations in stimulated NK cells. These so-called likelihood
curves were calculated for each individual phosphopeptide (green
curve) and comparatively inspected with a protein regulation
curve summarizing quantitative data of all non-phosphorylated
KCC2G peptides (gray curve). Phosphopeptides (phosphorylation
sites) were only accepted as differentially regulated upon receptor
engagement if their likelihood curves were clearly separated from
the protein regulation curve (Figure S3).
In this way, all 313 phosphorylation sites identified at 95 distinct
kinases (Table S3) were inspected quantitatively. Of those, 102
were detected in all experiments (Figure S4). In total, 22 tyrosine,
62 threonine, and 229 serine phosphorylation events were
observed. Thereof, 47 phosphorylations could not be assigned
unambiguously to an individual threonine/serine residue as
indicated by alternative phosphopeptide sequence annotations.
As expected, the majority of peptides, in particular the non-
modified peptide sequences, were not regulated significantly
following receptor activation. Cluster analyses of all regulation
data obtained from non-phosphorylated peptides showed a normal
distribution, whereas regulation factors of phosphorylated peptides
were distributed non-normally and exhibited a clear shift toward
positive regulation values (Figure S5).
Particular attention was paid to the validation of significantly
regulated phosphorylation sites determined by iTRAQassist [38],
which also required a distinct separation of individual phospho-
peptide populations. Nano ultra performance liquid chromatog-
raphy (nano-UPLC) could separate peptides based on their
sequence and number of modifications, but as is noteworthy, also
according to the specific site of phosphorylation. Thus, subpop-
ulations of isobaric phosphopeptides, such as the peptide
DGSLNQSSGYR originating from FYN, could be quantified
individually. Differentially phosphorylated peptide fractions rep-
resenting the DGSLNQSSGYR region of FYN were clearly
resolved by our chromatography and thus could be characterized
separately by MS (Figure 5). This allowed the annotation and
quantification of individual phosphorylation sites, even if modifi-
cations were located in close proximity. In the case of FYN, the
discrimination of two N-terminal regions (S21-S25-S26 and Y28),
inversely regulated by CD16 stimulation, was achieved (Figure 5
and Figure S6). Similarly, FYN was phosphorylated on the N-
terminal amino acids S21, S25 and S26 following co-engagement
of 2B4 and DNAM-1 (Figure S6). However, FYN exclusively
phosphorylated at S21 constituted the most prominent part of the
responding populations (Figure 5), whereas relatively small
amounts of FYN were phosphorylated at S25, S26 and in
particular Y28. Taken together, iTRAQassist-based statistical
evaluation of quantitative MS data complemented by manual
inspection of phosphopeptide elution profiles and fragmentation
spectra assured the significance of NK cell receptor-induced kinase
modifications in this study.
Kinase phosphorylations induced by CD16 and co-
engagement of 2B4 and DNAM-1
Kinase-mediated signaling downstream of NK cell activation
receptors had not been systematically investigated. Therefore, we
used NK cells from two human donors and comparatively studied
kinase phosphorylation induced by CD16 and co-engagement of
2B4 and DNAM-1. These experiments revealed 21 protein kinases
with altered phosphorylation sites after 2 minutes of CD16
engagement (Table 1 and Figure S3). Several phosphorylation
sites could not observed by MS under all conditions, which might
either reflect the limited sensitivity of this study or indicate donor
variations. However, the increased phosphorylation of FYN,
KCC2G, FES, and AAK1, as well as the reduced phosphorylation
of MARK2, were reproducibly observed in all experiments. 2B4
and DNAM-1 co-engagement generally led to a slightly weaker
phosphorylation of these phosphorylation sites, and according to
the statistical noise model iTRAQassist, some regulations did not
achieve a significant regulation score. However, with few
exceptions, phosphorylation induced by 2B4 and DNAM-1 co-
engagement was in accordance with that induced by CD16
engagement (Figure 6).
Only three of 21 kinases identified as significantly regulated
have been previously described as components of the CD16-
signaling pathway, i.e. LCK, LYN, and KPCT (PRKCQ/PKCh).
Our data indicate a CD16-induced dephosphorylation of LCK on
the inhibitory tyrosine Y192, increased phosphorylation of LCK
on the activating region Y394/T395, phosphorylation of LYN on
S38, dephosphorylation of LYN on serine S164 and phosphory-
lation of KPCT on S685. The dephosphorylation of LCK on
Y192 and phosphorylation of LYN on S38 were also observed in
NK cells co-activated by 2B4 and DNAM-1. Furthermore, kinases
implicated in NK cell function, but not specifically assigned to
CD16 signaling, i.e. FAK2, FGR, FYN, ITK, and KCC2G/D,
were phosphorylated upon CD16 stimulation. FAK2 was
dephosphorylated on the amino acids T842 and Y579, which is
part of the kinase domain, upon CD16 engagement or 2B4 and
DNAM-1 co-engagement. Engagement of CD16 and co-stimula-
tion of 2B4 and DNAM-1 induced phosphorylation of FGR on its
supposed auto-phosphorylation site Y412. Triggering of CD16 led
to the phosphorylation of FYN on the N-terminal serines S21,
S25, and S26, whereas the adjacent Y28 showed a trend toward
dephosphorylation (Figure S6). Phosphorylation of these serines
was also induced by co-engagement of 2B4 and DNAM-1.
Engagement of CD16 as well as co-engagement of 2B4 and
DNAM-1 also induced phosphorylation of KCC2G on S381–
S384 and KCC2D on S330, in addition to the tentative activation
site KCC2G on position 287 (based on sequence homology). For
ITK, phosphorylation of Y512 upon CD16 engagement was
increased in one donor but decreased in the other one. In contrast,
ITK Y512 phosphorylation was reduced following co-engagement
of 2B4 and DNAM-1.
The majority of kinases identified by our study have not been
characterized in NK cells before. Phosphorylation on the
activating Y714 of FER was reduced, as was FES phosphorylation
decreased on the activating Y713 by engagement of CD16 or co-
engagement of 2B4 and DNAM-1. In contrast, phosphorylation of
the proximate S716 residue of FES was significantly induced by
remaining kinases (black circles). Abbreviations: AGC, PKA/PKG/PKC-family kinases; CAMK, calcium/calmodulin-dependent kinases; CK1, casein
kinases; CMGC, CDK/MAPK/GSK3/CLK-family kinases; RCG, receptor guanylate cyclases; STE, sterile homologue kinases; TK, tyrosine kinases; TKL,
tyrosine kinase-like kinases; atypical protein kinases; Other, belonging to non of the mentioned groups. Human kinome provided courtesy of Cell
Signaling Technology, Inc. www.cellsignal.com.
doi:10.1371/journal.pone.0029672.g003
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PLoS ONE | www.plosone.org 6 January 2012 | Volume 7 | Issue 1 | e29672Figure 4. Quantification of kinase phosphorylation induced by activating NK cell receptors. ITRAQ-based quantification and statistical
analysis of kinase phosphorylation by iTRAQassist is exemplified for CD16- or 2B4 and DNAM-1-mediated phosphorylation of calcium/calmodulin-
dependent protein kinase II gamma (KCC2G). (A) MS/MS fragmentation spectrum of a tryptic phosphopeptide derived from KCC2G. Peptide
sequencing, protein identification and phosphorylation site annotation are based on fragment ions of the b- (red) and y- (blue) series. The sequence
of the phosphopeptide (GSTESCNTTTEDEDLK) is shown in the upper part of the diagram. On the right, a magnification of the low molecular mass
range is shown. The intensity of the iTRAQ reporter 114 correlates with the abundance of the respective phosphopeptide in IgG isotype control-
treated (cIgG) NK cells, whereas the intensities of the 115 and 116 peaks represent 2B4 and DNAM-1 co-stimulated or CD16-stimulated cells. The MS/
MS spectrum is derived from experiment II (see Table S1). (B) Statistical evaluation of CD16-induced KCC2G phosphorylation by iTRAQ assist.
Statistical analyses of phosphopeptide regulation were performed by iTRAQassist as described previously [38]. Most and less likely peptide
regulations (x-axis: regulation factors, RF) were calculated and depicted as likelihood curves (y-axis) for individual phosphopeptides (green curves).
The regulation of non-phosphorylated peptides assigned to KCC2G were calculated cumulatively and the resulting protein curve characterizes the
general kinase abundance (expression) under the condition of stimulation (gray curve, ‘‘kinase regulation’’). KCC2G was equally expressed in IgG
isotype control-treated and CD16-stimulated NK cells. Only phosphorylation sites having regulation curves clearly separated from the protein curve
were considered as regulated. CD16 stimulation (2 min) led to KCC2G phosphorylation on S381 and T382, but not on T287 (QETVECLR) or S311
(GAILTTMLVSR).
doi:10.1371/journal.pone.0029672.g004
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Further, MARK2 phosphorylation was significantly reduced on
S456 in NK cells following engagement of CD16 and co-
engagement of 2B4 and DNAM-1. Remarkably, PAK4 phos-
phorylation on S181 was diminished after CD16 engagement, but
significantly up-regulated upon co-engagement of 2B4 and
DNAM-1. Moreover, NK cell receptor activation led to the
phosphorylation of AAK1 and GAK, both of which are involved
in clathrin-mediated endocytosis. AAK1 phosphorylation on T620
was significantly enhanced following engagement of CD16 and co-
engagement of 2B4 and DNAM-1, whereas the region S672–S678
was reversely regulated. Our data also suggested the phosphory-
lation of GAK on S829 following CD16 activation. NK cell
activation via CD16 and or 2B4 and DNAM-1 co-engagement
also led to the phosphorylation of AAPK1 on its predicted auto-
phosphorylation site S496, enhanced phosphorylation of GSK3A
on the inhibitory site S21, phosphorylation of KPCD2 on S214,
phosphorylation of NEK9 on S331-T333 and PCTK2 phosphor-
ylation on S137 and S165. Furthermore, PRPK was phosphor-
ylated on T8 in response to CD16 engagement. In summary,
proteome analysis of receptor-induced kinase phosphorylation
implicated several new kinases in the regulation of NK cell
activation.
Discussion
The potential of kinase-selective phosphoproteomics (phospho-
kinomics) to provide comprehensive access to the human kinome
has previously been demonstrated [10,33,39,40]. Our results
provide a snap-shot of kinase phosphorylation in NK cells shortly
after crosslinking of different activating receptors and identify
several kinases not previously implicated in NK cells signaling that
are regulated downstream of receptor engagement. To our
knowledge, this study is the first to employ phosphokinomics to
systematically analyze proximal kinase signaling in primary
immune cells.
Phosphokinomics is useful for the systematic characterization of
kinase-based signaling on a minute time scale [41,42]. MS-based
characterization of phosphorylation events at the level of low
abundant protein kinases currently still requires a large amount of
cell material and therefore has been restricted to immortalized cell
lines. An expansion protocol facilitated the generation of sufficient
material (up to 1,5610
9 NK cells) for phosphokinome analyses.
Importantly, as compared to freshly isolated NK cells, IL-2–
cultured NK cells were not significantly altered with respect to the
expression of activation receptors, kinetics of intracellular calcium
mobilization, or magnitude of degranulation following receptor
stimulation. The non-specific kinase inhibitor VI16743 in
combination with the commercially available ATP-competitor
Purvalanol-B were used to capture the kinome and phosphoryla-
tion status of stimulated NK cells. The number of kinases
identified by our workflow equaled the number of kinases detected
by chemical proteome approaches using a pool of 5 different
kinase inhibitors [33,39,40,42] and exceeded the amount of
kinases captured by VI16743 alone [33]. MS data verified the
expression of 175 protein kinases (and 13 non-protein kinases)
from virtually all branches of the human kinome. Although
physiological kinase phosphorylation states and activities in
Figure 5. Identification of differentially phosphorylated FYN subsets in NK cells. Nano ultra performance liquid chromatography (nano-
UPLC) dissects distinct phosphorylation events at the same peptide DGSLNQSSGYR derived from the protein kinase FYN. MS analyses determined
phosphorylations at the amino acid residues S21, S25, S26 and Y28. Successive elution of distinct phosphopeptides based on the same amino acid
sequence facilitated the precise quantification of each phosphorylation event at FYN by MS (Figure S6). All phosphorylated serines showed a
significantly induced phosphorylation following receptor engagements. However, the relative signal intensities of the distinct phosphopeptide
populations indicate a predominant abundance of FYN phosphorylated on S21.
doi:10.1371/journal.pone.0029672.g005
The Human NK Cell Kinome
PLoS ONE | www.plosone.org 8 January 2012 | Volume 7 | Issue 1 | e29672primary cells are probably lower than compared to immortalized
cell lines, we obtained quantitative information on more than
300 distinct phosphorylation sites. MS-based analysis of
phosphopeptide regulation was assisted by a nano-UPLC system
enabling the distinct separation of even isobaric phosphopeptides
(identical amino acid sequence but different position of
modification). This further supported the unambiguous charac-
terization of phosphorylation sites by high-accuracy MS and the
exclusion of compromised iTRAQ reporter signals for their
quantitative analyses. Finally, statistical evaluation identified
kinases significantly regulated by engagement of CD16 or co-
engagement of 2B4 and DNAM-1. Our study revealed 21
kinases on which phosphorylation was modulated upon NK cell
receptor stimulation. However, not all of the kinase regulations
could be confirmed in each experiment. Besides potential
variations in human donors, a limited sensitivity and randomized
selection of low-abundant peptide ions during LC-MS experi-
ments always cause some variations in the number of identified
phosphopeptides, which then obligatory coincide with missing
quantitative information.
Many of the regulated kinases presented in this study have not
been previously described in NK cells (Table 1 and Figure 6). For
most regulated sites, phosphorylation induced by CD16 engage-
ment or 2B4 and DNAM-1 co-engagement demonstrated a similar
pattern, in agreement with the notion of a convergence of signals
for NK cell activation [26]. However, PAK4 phosphorylation on
S181 was induced by co-stimulation of 2B4 and DNAM-1, but
reduced following CD16 engagement (Figure 6). Preliminary
experiments with single receptor stimulations suggest that PAK4
phosphorylation on S181 is induced by 2B4, but not DNAM-1.
Thus, PAK4 may be downstream of 2B4 engagement. In T cells,
2B4 can recruit PIX (PAK interacting exchange factor), a PAK-
Rac/Cdc42-specific guanine-exchange factor (GEF), via its
adapter protein SAP [43,44]. Thus, PAK4 might link proximal
2B4 signaling to actin cytoskeleton rearrangements and be
dependent on the SAP/PIX adapter complex. In contrast to
Table 1. Kinase phosphorylation induced by CD16 (2 min).
Kinase
1
Phosphorylation-site
function
2 and regulation
3 Function
4 References
5
NK cell function
$
FAK2
T842, FAK2
Y579 N/K, N/K down, down Natural cytotoxicity, integrin signaling, IL15-mediated
NK cell priming
[69] [70]
FGR
Y412 (A) up IFNc production [71]
FYN
S21-S25-S26,F Y N
Y28 A/N/K/*, (A) up, down 2B4 signaling, LFA-1-dependent DNAM-1 phosphorylation [19] [45] [46] [25]
ITK
Y512 A donor-
dependent
Fc receptor and NKG2D signaling [72]
KCC2G
T287, KCC2G
S381–S384 (A), N/K up, up LFA-1-dependent NK cell activation by DCs [50]
KCC2D
S330 N/K up LFA-1-dependent NK cell activation by DCs [50]
KPCT
S685 N/K up NK cell activation, CD16 and 2B4 signaling [73] [74] [75] [76] [77] [78] [79]
LCK
Y192,L C K
Y394 or T395 I, A/* down, up NK cell activation, CD16 signaling [80] [81] [82] [83]
LYN
S38,L Y N
S164 *, * up, down CD16 signaling [81]
Cytoskeleton rearrangement and degranulation
1
FER
Y714 A down Cytoskeleton dynamic, FceRI signaling [62] [63]
FES
S716, FES
Y713 N/K, A up, down Cytoskeleton dynamic, FceRI signaling, vesicle
trafficking and degranulation
[62] [63] [84] [64]
MARK2
S456 N/K down Mikrotubuli reorganization, granula exocytosis [66] [85]
PAK4
S181 N/K down Actin cytoskeleton dynamic, adhesion [43] [44]
Clathrin-mediated endocytosis
1
AAK1
T620, AAK1
T672-S678 N/K, N/K up, down Clathrin-mediated endocytosis [86] [87] [88]
GAK
S829 N/K up Clathrin-mediated endocytosis [86] [87] [88]
Other
1
AAPK1
S496 (A) up ATP-dependent biosynthesis [89] [90]
GSK3A
S21 I up PI3K/Akt-, NFAT signaling [91] [92]
KPCD2
S214 N/K up DAG/phorbol ester, NFAT signaling [93] [94]
NEK9
S331-T333 N/K up Cell cycle [95] [96]
PCTK2
S137, PCTK2
S165 N/K, N/K up, up Potential role in terminally differentiated neurons [97] [98]
PRPK
T8 N/K up p53/TP53 regulation [99]
Footnote: Kinases listed here are (
$) involved in or (
1) so far not associated with NK cell function and/or CD16 signaling;
1)UniProt name of kinase and phosphorylation site annotation;
2)Function of phosphorylation site (A, activation; I, inhibition; brackets indicate possible function based on sequence homology; N/K, not known; *, novel
phosphorylation site according to PhosphoSitePlus database);
3)Direction of phosphorylation site regulation induced by CD16 (up: up-regulation, down: down-regulation, donor-dependent regulation;
4)Kinase function and.
5)PubMed references.
doi:10.1371/journal.pone.0029672.t001
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tent regulation of phosphorylation sites on five kinases (FYN,
KCC2, AAK1, FES and MARK2) following stimulation with
different receptors.
FYN was consistently phosphorylated upon engagement of all
receptors investigated on its N-terminal serines S21, S25 and S26,
but phosphorylation of the adjacent tyrosine Y28 was unchanged
or even reduced. FYN is known to play an important role in
proximal signaling by 2B4 [19,45,46]. Additionally, FYN is
involved in DNAM-1-mediated signaling, as has previously been
demonstrated in T cells and mast cells [47,48]. A role for FYN in
NK cell signaling downstream of CD16 has not been described.
FYN phosphorylation on S21 and S25 has been identified by other
systematic phosphoproteome approaches, whereas FYN phos-
phorylation on S26 is novel. Interestingly, recent work suggests
that FYN is phosphorylated by PKA on S21 and that this
phosphorylation can regulate FYN activity and reduce focal
adhesion dynamics [49]. Our data support the idea that S21 plays
an important functional role: S21 showed a significantly regulated
phosphorylation and constituted the most abundant FYN
population in comparison to alternative phosphorylations at S25,
S26 and Y28. Together, these data point to a central role for FYN
in NK cell activation mediated by different activating NK cell
receptors.
The calcium/calmodulin-dependent kinase 2 (KCC2, CAMK2)
subunits gamma and delta were phosphorylated on S381–S384
and S330 following CD16 engagement or 2B4 and DNAM-1 co-
engagement. Furthermore, our data suggests simultaneous phos-
phorylation of the S287 activation site on KCC2G. Poggi and
colleagues have demonstrated that pharmacological inhibition of
KCC2 blocks IL-2–cultured NK cell killing of autologous
dendritic cells, but not of K562 cells [50]. In T cells, TCR
engagement induces translocation of KCC2 to the immune
synapse where KCC2 facilitates activation of NFkB through
phosphorylation of CARMA1 and Bcl10 [51,52]. Data also
suggest that KCC2 can negatively regulate NFAT activation,
diminishing cytokine transcription in T cells [53]. Taken together,
although our data implicate activation of KCC2 downstream of
activating NK cell receptor engagement, it is not clear how KCC2
modulates NK cell effector functions.
Results revealed that AAK1, the ubiquitously expressed AP2
associated kinase 1 implicated in clathrin-mediated endocytosis
[54,55], possesses a high basal serine/threonine phosphorylation
in the region T606-S690. Following engagement of CD16 or co-
engagement of 2B4 and DNAM-1, phosphorylation of T672-S678
was reduced. Conversely, stimulation induced AAK1 phosphor-
ylation on T620. Thus, this regulation may potentially serve as
molecular switch controlling AAK1 function. AAK1 function has
Figure 6. Kinase phosphorylation induced by engagement of CD16 or co-engagement of 2B4 and DNAM-1. CD16- (two proteome
experiments) or 2B4 and DNAM-1 co-activated (three proteome experiments) NK cells from two healthy human donors were analyzed in this study.
(A) Kinases, which have previously been associated with NK cell signaling and/or function. (B) Putative novel CD16- and/or 2B4 and DNAM-1-
dependent signaling components.
1)UniProt name of kinases and phosphorylation site annotation; regulation of phosphorylation site following
2)CD16 engagement or
3)2B4 and DNAM-1 co-activation is indicated as follows: green, up-regulated; red, down-regulated; gray, no statistical
significant phosphorylation site regulation was detected; Number of (filled) circles indicates how often the significant regulation of a respective
phosphorylation site was detected according to iTRAQassist (no overlap of protein and respective phosphopeptide regulation curves).
Phosphorylation sites regulated with the same tendency, but not matching the criteria of statistical significance are marked as open circles.
Proteome experiments that failed to detect a respective phosphorylation site are indicated by n.d. (not detected).
doi:10.1371/journal.pone.0029672.g006
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several NK cell receptors have been shown to undergo SRC-
dependent internalization [56]. Moreover, juxtaposed to an
exocytic pathway, endocytosis is a prominent feature of the
cytotoxic NK cell synapse [57]. The significance and molecular
architecture of endocytosis in regard to NK cell cytotoxicity
remains to be elucidated.
Stimulation of CD16 or 2B4 and DNAM-1 induced FES
phosphorylation of S716 and dephosphorylation of the postulated
auto-phosphorylation site Y173 [58,59], suggesting a regulation of
FES activity following NK cell receptor engagement. FES is a
SRC family kinase involved in cytoskeleton rearrangements
[60,61]. In mast cells, FES participates in FceRI-receptor-induced
degranulation [62,63,64]. Hence, FES might also regulate NK cell
degranulation.
MARK2 was consistently dephosphorylated on S456 following
engagement of CD16 or co-engagement of 2B4 and DNAM-1.
MARK family kinases phosphorylate microtubule-associated
proteins, regulate microtubule-based intracellular transport, and
are implicated in cellular polarity [65]. In T cells, MARK2 has
been shown to become phosphorylated on S400 and T595
following TCR engagement and be required for microtubule-
organizing center polarization [66]. Thus, it will be interesting to
investigate how MARK2 might contribute to NK cell cytotoxicity.
This study characterizes a significant portion of the NK cell
kinome and provides a first unbiased and systematic view into
kinase signaling in primary NK cells. Proteomics detected
receptor-dependent kinase phosphorylations already after 2 min-
utes of receptor engagement and allowed the discrimination of
differentially phosphorylated kinase populations as demonstrated
by FYN. Several kinases were consistently regulated following the
engagement of activating receptors. Co-engagement of DNAM-1
and 2B4 generates a phosphorylation pattern at kinases, which was
rather similar to that of CD16-stimulated cells, supporting the idea
of a core signal network for NK cell activation. Kinases and
phosphorylations, which have not previously been implicated in
NK cell signaling were regulated and may thus contribute to the
process of NK cell activation. Regulation of kinases such as
MARK2 and AAK1 are interesting in terms of understanding the
molecular pathways for cellular polarization and endocytosis,
processes that are induced upon NK cell activation. Thus,
contemplating data presented here will direct future studies
focused on elucidating the molecular regulation of NK cell
effector functions.
Materials and Methods
Cells
This study was approved by The Regional Ethics Review Board
in Stockholm. Peripheral blood was obtained with informed
consent from healthy volunteers. Peripheral blood mononuclear
cells (PBMCs) were isolated by density gradient centrifugation
(Lymphoprep, Axis-Shield). NK cells were subsequently purified
by negative magnetic selection (NK cell isolation kit, Miltenyi
Biotec). Freshly isolated NK cells were resuspended in complete
medium (RPMI 1640 supplemented with 2 mM L-glutamine and
10% fetal bovine serum [FBS], all Invitrogen) and analyzed within
two days after isolation. For polyclonal expansion, purified NK
cells (10
5 per well) and irradiated, allogeneic PBMCs (10
5 per well)
were resuspended in complete medium supplemented with
500 U/ml recombinant IL-2 (Proleukin, Roche) and 10 mg/ml
PHA-L (Sigma). Cells were co-cultured in 96-well plates for one
week. NK cells were transferred to culture flasks and cultured
further for 2 weeks in complete medium supplemented with 50 U/
ml IL-2. The purity and viability of NK cells were assessed by flow
cytometry prior to analysis. The percentage of CD3
2CD56
+ NK
cells was greater than 95% in all experiments.
The human erythroleukemia cell line K562 and murine
mastocytoma cell line P815 (both American Type Culture
Collection) were maintained in complete medium.
Antibodies and fluorescent reagents
Forflowcytometry,NKcellactivation,calciumfluxanalyses,and
CD107a degranulation assays, the following mouse monoclonal
antibodies (mAbs) were used: anti-CD107a (clone H4A3, IgG1),
anti-CD16 (clone 3G8, IgG1), anti-CD56 (clone NCAM16.2,
IgG2b, or B159, IgG1), anti-DNAM-1 (clone DX11, IgG1), anti-
NKG2D (clone 1D11, IgG1), and anti-CD3 (clone UCHT1, IgG1;
all BD Biosciences), anti-2B4 (clone C1.7, IgG1, Beckman Coulter),
and isotype control mAb (clone MOPC-21, Sigma-Aldrich). For
determination of intracellular calcium mobilization, the calcium-
sensitive dyes Fluo-4 and FuraRed (both Molecular Probes) were
used.
Calcium flux analysis
NK cells were resuspended in 50 ml Hanks buffered salt solution
(HBSS, Biosource) and incubated with the primary mAbs
indicated (1 mg mAb per 10
7 NK cells) for 30 min on ice. 300 ml
staining solution (HBSS supplemented with 1% FBS, 2 mM Fluo-4
AM, 5 mM Fura Red AM, and 5 mM Probenecid) were added,
and cells were incubated for an additional 30 minutes at 4uC.
Dye-loaded NK cells were washed, resuspended in HBSS, and
kept on ice. Prior to analysis NK cells were resuspended in 300 ml
HBSS supplemented with 1% FBS, pre-warmed at 37uCi na
water bath, and analyzed by flow cytometry. After 30 seconds,
samples were removed from the flow cytometer, and F(ab9)2-anti-
mouse IgG crosslinking antibodies (2 mg Ab per 10
7 NK cells;
Jackson ImmunoResearch) were added. Thereafter, samples were
measured for 4 minutes by flow cytometry. Acquired flow
cytometric data were analyzed using the FlowJo software
(Treestar). NK cells were gated on forward/side scatter, and the
ratios of FL-1 and FL-3 intensities were displayed as a function of
time.
CD107a degranulation assay
For assessment of NK cell degranulation, 2610
5 K562 cells or
2610
5 P815 target cells pre-incubated with 5 mg/ml of the
indicated mAbs for 30 minutes at room temperature were mixed
with 1610
5 NK cells for one hour at 37uC in complete medium.
Thereafter, the cells were centrifuged and resuspended in FACS
buffer (PBS supplemented with 2% FBS and 2 mM EDTA)
containing fluorochrome-conjugated anti-CD56 and anti-CD107a
mAbs, and analyzed by flow cytometry. Data were analyzed with
FlowJo software.
IL-2–cultured NK cell stimulation for phosphokinome
analysis
For kinome experiments, up to 1,5610
9 IL-2-cultured NK cells
were used (5610
8 NK cells per stimulation). IL-2-cultured NK
cells were starved overnight in complete medium without IL-2.
Prior to stimulation, cells were resuspended in complete medium
at 2610
7 cells/ml. NK cells were incubated with primary mAbs
directed against CD16, DNAM-1 and 2B4 for 30 minutes on ice
(1 mg mAb per 10
7 NK cells). MAb-coated NK cells were pre-
warmed at 37uC in a water bath, thereafter added F(ab9)2-anti-
mouse-IgG crosslinking antibody (Jackson ImmunoResearch), and
stimulated for the indicated time.
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Following stimulation, NK cells were lysed in ice-cold lysis
buffer containing 50 mM HEPES pH 7.5, 1 M NaCl, 1 mM
EGTA, protease inhibitor cocktail (Roche), and 1% Triton-X100.
Lysates were centrifuged at 700006g for 30 minutes at 4uC and
filtered using a 0.45 mm syringe membrane (Millipore). The
protein concentrations of lysates were determined using a
Bradford protein assay (BioRad) to ensure equal loading of kinase
affinity columns. For small molecule affinity chromatography
(SMAC), the kinase inhibitors VI16743 and Purvalanol-B (Tocris)
were used. Synthesis of V16743 and generation of both kinase
affinity materials were conducted as previously described [10,41].
Columns (5/50 Tricorn, GE Healthcare) were equilibrated with
buffer A (50 mM HEPES-NaOH pH 7.5, 1 M NaCl, 1 mM
EGTA, 1 mM EDTA, 0.1% Triton-X100), loaded with NK cell
lysates (3 ml/h), washed with 60 column volumes of buffer A
(6 ml/h), and equilibrated (2 h, 6 ml/h) with buffer B (50 mM
HEPES-NaOH pH 7.5, 1 mM EGTA, 1 mM EDTA, 0.1%
Triton-X100). Kinase-enriched fractions were eluted (6 ml/h)
separately with 0.5% SDS at room temperature. Eluates were
pooled and concentrated by vacuum centrifugation.
Peptide generation and iTRAQ labeling
Proteins were extracted from concentrated SMAC eluate
fractions by chloroform/methanol precipitation [67]. Protein
dissolution, denaturation, tryptic digestion, and quantitative
peptide labeling by iTRAQ were performed according to the
manufacturer’s guidelines (Applied Biosystems). Following label-
ing, peptides derived from IgG isotype control-, CD16 or 2B4 and
DNAM-1 co-stimulated NK cells were combined and pooled
samples were vacuum-dried, and peptides were desalted using self-
packed LiChroprep RP-18 SPE columns (Merck). To quantify
kinase phosphorylation induced by CD16, individually, or the co-
engagement of 2B4 and DNAM-1, the following iTRAQ-labels
were used: experiments I and II (cIgG:114, 2B4/DNAM-1:115,
CD16:116), and experiment III (cIgG:114, 2B4/DNAM-1: 117).
Phosphopeptide enrichment and peptide fractionation
Phosphorylated peptides (phosphopeptides) were enriched from
complex peptide samples using the following immobilized metal
affinity chromatography (IMAC) protocol: iTRAQ-labeled and
desalted peptide mixtures were resolved in IMAC binding buffer
(1:1:1 methanol:acetonitrile:H2O containing 2% acetic acid,
pH 2.8) and incubated with two Ga
3+-chelated gel disks (Pierce)
for one hour at room temperature or overnight at 4uC. The Ga
3+-
matrix was washed 3 times with 100 ml IMAC-binding buffer to
remove unmodified peptides. Retained phosphopeptides were
eluted with 600 ml IMAC elution buffer (100 mM ammonium
phosphate buffer, pH 4.5). The phosphopeptide-enriched fraction
was vacuum-dried, desalted and analyzed by LC-MS/MS. IMAC
flow-through and washing fractions were collected and constituted
the phosphopeptide-depleted fraction. The phosphopeptide-deplet-
ed fraction was further sub-fractioned by SCX chromatography.
Thereafter, desalted peptides were resolved and separated on a
MonoS PC1.6/5 column (GE Healthcare) using an Ettan micro LC
system (GE Healthcare). SCX-separated peptide fractions were
vacuum-dried, desalted, and analyzed separately by LC-MS/MS.
LC-MS/MS analysis and database search
LC-MS/MS analyses of phosphopeptide-enriched and -deplet-
ed fractions were performed on an Acquity Ultra Performance LC
system (Waters Corp.) connected to an LTQ Orbitrap XL Fourier
transform mass spectrometer (Thermo Scientific). Raw MS data
were converted to data formats compatible with Mascot search
engine (Matrix Science). Data from all peptide fractions were
merged using Mascot Daemon (version 2.1.6). The UniProtKB/
Swiss-Prot primary sequence database was used for protein
identification (release 2011_03, with 525,997 entries; taxonomy
Homo sapiens with 20,226 entries). In this study, proteins were only
considered if they were identified at least with one unique peptide
having an individual Mascot peptide score above 20, which
indicated identity or extensive homology (p,0.05) using the
following Mascot search parameters: enzyme, trypsin (specificity:
K/R); maximum missed cleavages, 1; fixed modifications, iTRAQ
4-plex (K), iTRAQ (N terminus), Methylthio (C); variable
modifications, phosphorylation (S, T, Y), oxidation (M); peptide
tolerance, 10 ppm; MS/MS tolerance, 0.1 Da. Proteins identified
by one peptide and Mascot-aided assignment of tyrosine (Y)
phosphorylation (n=21) were checked by manual inspection of
corresponding MS/MS spectra, whereas annotation of threonine
(T, n=63) and serine (S, n=209) phosphorylation was statistically
validated by the AScore algorithms [68]. False discovery rates
(FDRs) were calculated using the software Scaffold (version
Scaffold_3_00_06). On average peptide FDRs less than 1.4%
were determined. All MS-data associated with this manuscript are
published in the PROteomics IDEntifications Database (PRIDE)
(www.ebi.ac.uk/pride/).
Evaluation of quantitative LC-MS/MS data
Statistical evaluation of quantitative peptide data was conducted
by iTRAQassist, a MS device-specific noise algorithm, as
previously described [38]. Briefly, statistical evaluation was
performed on the basis of spectral data derived from Mascot
result files (.dat files) and restricted to peptides uniquely and
unambiguously identified within the particular MS/MS data set
(peptide tolerance: 10 ppm; MS/MS tolerance: 0.1 Da; iTRAQ
reporter mass delta: 0.02 Da). ITRAQassist combines iTRAQ by-
product correction and normalization of iTRAQ intensities with a
noise-specific algorithm allowing determination of a weighted
cumulative regulation factor for each unique peptide and
prediction of possible deviations from the calculated regulation
values dependent on iTRAQ reporter quality. ITRAQ reporter
intensities were re-calculated according to certified and experi-
mentally confirmed ratios of isotopic impurities of the different
iTRAQ reporter molecules. The subsequent normalization was
accomplished by comparing the trimmed mean of reporter
intensities in all samples and discarding the upper and lower
20% of reporter intensities. Peptide regulations were depicted as
likelihood curves for every peptide. Peptides containing phosphor-
ylated amino acids were accepted as differentially regulated if their
corresponding likelihood curves (phosphopeptide curve) were
clearly separated from the cluster of non-phosphorylated peptides
belonging to the same protein (protein curve). Regulated and
discussed phosphopeptide sequence qualities and phosphorylation
site annotations were examined manually.
Supporting Information
Figure S1 Purity of IL-2–cultured primary NK cells. (A)
PBMC obtained from human peripheral blood by Ficoll gradient
centrifugation and (B) IL-2–cultured NK cell were stained with
fluorochrome-conjugated anti-CD3 and anti-CD56 mAbs and
analyzed by flow cytometry. IL-2–cultured NK cell were 95 to
99% CD3
2CD56
+ as determined by flow cytometry. Data
represent IL-2–cultured NK cell populations used in the
phosphoproteome studies.
(PDF)
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matography permits comprehensive enrichment of
human protein kinases. (A) Kinases were significantly
enriched by VI16743/Purvalanol-B-based affinity chromatogra-
phy. Percentages of kinases and non-kinases (others: proteins
without kinase activity) after VI16743/Purvalanol-B-mediated
affinity purification are shown. (B) Kinases are identified based
on a significantly higher number of MS spectra reflecting a better
peptide identification and coverage of kinases achieved by MS.
Assigned MS spectra per kinase and non-kinases (others) are
depicted as mean values 6 standard deviation (SD) of all
conducted kinase-selective phosphoproteome experiments. Differ-
ences between two groups were examined using the Student’s t-test
(***, p,0.001).
(PDF)
Figure S3 Statistical validation of phosphorylation site
regulation at protein kinases by iTRAQassist. Statistical
evaluation of quantitative peptide data was conducted by
iTRAQassist, a MS device specific noise algorithm, as previously
described [38]. Phosphorylation sites were accepted as differen-
tially regulated if their corresponding likelihood curves (phospho-
peptide curve, green) were clearly separated from the cluster of
non-phosphorylated peptides belonging to the same protein
(protein curve, gray).
(PDF)
Figure S4 Number of kinase phosphorylation sites
identified in respective experiments.
(PDF)
Figure S5 Distribution of iTRAQ-based protein and
phosphorylation site regulation factors. This figure pro-
vides a general overview of all protein (black curve) and
phosphorylation site (red curve) regulation factors calculated for
two representative proteome experiments (I and II, see Table S1).
Protein regulations are given as cumulative regulation values
calculated on the basis of all non-phosphorylated peptides
belonging to the same kinase. The majority of non- and
phosphorylated peptides were expectedly not regulated. Protein
regulation factors showed a normal distribution, whereas the
phosphorylation site curve exhibits a non-normal distribution and
was clearly shifted towards positive regulation values.
(PDF)
Figure S6 ITRAQ-MS-based quantification of N-termi-
nal FYN phosphorylation induced by the engagement of
CD16 or 2B4 and DNAM-1. Distinct phosphopeptide popula-
tions were resolved by nano-UPLC (Figure 5) and separately
analyzed by mass spectrometry. The figure shows MS/MS
fragmentation spectra of distinct FYN phosphopeptides originat-
ing from the same peptide sequence (DGSLNQSSGYR). FYN
identification and phosphorylation site annotation are based on
fragment ions of the b- and y-series (color code: red, b-ion; purple,
b-ions minus 98; blue, y-ions; turquoise, y-ions minus 98; green,
intensities of iTRAQ reporters or parent ions or b-ions minus
H2O). Relative iTRAQ intensities of the corresponding phospho-
peptides are shown at the right. FYN was differentially
phosphorylated at S21, S25, S28 and Y28 following engagement
of CD16 or co-engagement of 2B4 and DNAM-1.
(PDF)
Table S1 Performed phosphokinome experiments. Foot-
note: In experiment I and II cIgG-, CD16- and 2B4 and DNAM-1
co-activated NK cells were analyzed. In experiment III cIgG- and
2B4 and DNAM-1 co-activated NK cells were analyzed.
1Mascot-
based annotation of serine and threonine phosphorylation was
checked by the AScore algorithm. 47 phosphorylation sites could
not be assigned unambiguously.
(PDF)
Table S2 Kinases expressed in human NK cells. Foot-
note: *Kinase grouping according to Manning et al., 2002.
(PDF)
Table S3 Kinase phosphorylation in human NK cells.
Footnote:
1Serine/threonine annotations by Mascot were validat-
ed using AScore algorithm [68];
apredicted phosphorylation site
(UniProt); *not listed in UniProt database; when phosphorylation
sites could not be assigned unambiguously, alternative sequences
are given. Note: Only for peptides containing more than one single
serine/threonine residue AScore is required and annotation of
tyrosine phosphorylation is not evaluated by AScore algorithm,
but was inspected manually.
(PDF)
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